APS - ALTERATION
Brief description of study
Reliance Agreement requested with VUMC (IREx).
Creation of an observational phenotyping cohort of patients with acute respiratory distress syndrome, pneumonia or sepsis. Clinical risk factors, molecular phenotypes, and illness trajectories during the acute and recovery phases of these critical illness syndromes to be assessed. Alteration protocol describes the minimal risk study procedures initially done under waiver of consent. Consent then sought throughout study participation.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
